The N-Terminal Region of the Ryanodine Receptor Affects Channel Activation

Andrea Faltinova1,2, Nataša Tomaskova3, Marián Antalik3

  • 1Department of Muscle Cell Research, Institute of Molecular Physiology and Genetics of the Centre of Biosciences, Slovak Academy of SciencesBratislava, Slovakia.

Insights

Domain peptides mimicking inherited cardiac arrhythmias activate the cardiac ryanodine receptor (RyR2) channel. Structural modeling reveals how DPcpvtN2 peptide binding alters RyR2 conformation and activity, challenging existing mechanisms.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Biology
  • Biophysics

Background:

  • Mutations in the cardiac ryanodine receptor (RyR2) cause inherited cardiac arrhythmias.
  • Disease-associated RyR2 mutations can be mimicked by specific domain peptides that activate the channel.

Purpose of the Study:

  • To investigate the molecular mechanism by which the DPcpvtN2 domain peptide activates the RyR2 channel.
  • To elucidate the structural basis of RyR2 activation by DPcpvtN2 and compare it with mutation-induced conformational changes.

Main Methods:

  • Computational structural modeling of the interaction between DPcpvtN2 and the RyR2 N-terminal region.
  • Analysis of conformational changes in RyR2 upon peptide binding and mutation.

Main Results:

  • DPcpvtN2 peptide activates the RyR2 channel.
  • A specific structural model explained the concentration-dependent activation of RyR2 by DPcpvtN2.
  • The binding mechanism differs from the proposed 'domain switch' model.
  • DPcpvtN2 binding induces conformational changes distinct from those caused by mutations in the central helix.

Conclusions:

  • DPcpvtN2 peptide binding and central helix mutations similarly affect RyR2 transition energy, explaining channel activation.
  • The findings challenge existing models of RyR2 regulation by domain peptides and mutations.

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
6.1K
Relaxation of Skeletal Muscles01:29

Relaxation of Skeletal Muscles

The period of muscle contraction primarily influences the duration of stimulation at the neuromuscular junction (NMJ), the presence of free calcium ions in the sarcoplasm, and the availability of energy or ATP to support contractions.
When an action potential reaches the axon terminal, it depolarizes the membrane and opens voltage-gated sodium channels. Sodium ions enter the cell, further depolarizing the presynaptic membrane. This depolarization causes voltage-gated calcium channels to open....
6.2K
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
1.9K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.7K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
3.8K
Cholinergic Receptors: Nicotinic01:15

Cholinergic Receptors: Nicotinic

Nicotinic receptors are ligand-gated ion channels that are activated by acetylcholine and nicotine. Upon activation, they cause a rapid increase in the permeability of cells to K+, Na+, and Ca2+, followed by depolarization and excitation. They are in the autonomic ganglia, skeletal neuromuscular junction, CNS, and adrenal medulla.
There are two types of nicotinic receptors: neuromuscular (NM/NM/N1) and neuronal (NN/NN/N2). The two families differ based on their location and selectivity to...
6.0K